Inhibition of thrombospondin-1 reduces glutathione activity and worsens acute liver injury during acetaminophen hepatotoxicity in mice

Abdollah, 1997, TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling, J. Biol. Chem., 272, 27678, 10.1074/jbc.272.44.27678 Akino, 2018, Activation of Nrf2 might reduce oxidative stress in human granulosa cells, Mol. Cell. Endocrinol., 470, 96, 10.1016/j.mce.2017.10.002 Bachhawat, 2018, The glutathione cycle: glutathione metabolism beyond the gamma-glutamyl cycle, IUBMB Life, 70, 585, 10.1002/iub.1756 Baenziger, 1972, Isolation and properties of a thrombin-sensitive protein of human platelets, J. Biol. Chem., 247, 2723, 10.1016/S0021-9258(19)45271-X Bernal, 2015, Acute liver failure: a curable disease by 2024?, J. Hepatol., 62, S112, 10.1016/j.jhep.2014.12.016 Bird, 2018, TGFbeta inhibition restores a regenerative response in acute liver injury by suppressing paracrine senescence, Sci. Transl. Med., 10, 10.1126/scitranslmed.aan1230 Chen, 2000, The cell biology of thrombospondin-1, Matrix Biol., 19, 597, 10.1016/S0945-053X(00)00107-4 Chen, 2016, Thrombospondin-1 might be a therapeutic target to suppress RB cells by regulating the DNA double-strand breaks repair, Oncotarget, 7, 6105, 10.18632/oncotarget.6835 Crawford, 1998, Thrombospondin-1 is a major activator of TGF-beta1 in vivo, Cell., 93, 1159, 10.1016/S0092-8674(00)81460-9 Cunha, 2016, Thrombospondin 1 protects pancreatic beta-cells from lipotoxicity via the PERK-NRF2 pathway, Cell Death Differ., 23, 1995, 10.1038/cdd.2016.89 Daubon, 2019, Deciphering the complex role of thrombospondin-1 in glioblastoma development, Nat. Commun., 10, 1146, 10.1038/s41467-019-08480-y DeMorrow, 2008, The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway, Am. J. Physiol. Gastrointest. Liver Physiol., 295, G1150, 10.1152/ajpgi.90455.2008 Ebisawa, 2001, Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation, J. Biol. Chem., 276, 12477, 10.1074/jbc.C100008200 El-Youssef, 1999, Increased expression of transforming growth factor-beta1 and thrombospondin-1 in congenital hepatic fibrosis: possible role of the hepatic stellate cell, J. Pediatr. Gastroenterol. Nutr., 28, 386, 10.1097/00005176-199904000-00008 Fan, 2018, Isoorientin ameliorates APAP-induced hepatotoxicity via activation Nrf2 antioxidative pathway: the involvement of AMPK/Akt/GSK3beta, Front. Pharmacol., 9, 1334, 10.3389/fphar.2018.01334 Frampton, 2012, Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism, Gut., 61, 268, 10.1136/gutjnl-2011-300643 Grant, 2018, Direct comparison of the thioacetamide and azoxymethane models of type a hepatic encephalopathy in mice, Gene Expr., 18, 171, 10.3727/105221618X15287315176503 Jefferson, 2020, Thrombospondin-1 exacerbates acute liver failure and hepatic encephalopathy pathology in mice by activating transforming growth factor beta1, Am. J. Pathol., 190, 347, 10.1016/j.ajpath.2019.10.003 Jin, 2019, Quercetin attenuates toosendanin-induced hepatotoxicity through inducing the Nrf2/GCL/GSH antioxidant signaling pathway, Acta Pharmacol. Sin., 40, 75, 10.1038/s41401-018-0024-8 Kavsak, 2000, Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation, Mol. Cell, 6, 1365, 10.1016/S1097-2765(00)00134-9 Khalil, 1999, TGF-beta: from latent to active, Microbes Infect., 1, 1255, 10.1016/S1286-4579(99)00259-2 Kim, 2017, Disturbed flow promotes arterial stiffening through thrombospondin-1, Circulation, 136, 1217, 10.1161/CIRCULATIONAHA.116.026361 Kumar, 2017, TGF-beta activation by bone marrow-derived thrombospondin-1 causes Schistosoma- and hypoxia-induced pulmonary hypertension, Nat. Commun., 8, 15494, 10.1038/ncomms15494 Kuo, 2008, Gamma-H2AX - a novel biomarker for DNA double-strand breaks, In Vivo, 22, 305 Liu, 2016, Smad2 and Smad3 have differential sensitivity in relaying TGFbeta signaling and inversely regulate early lineage specification, Sci. Rep., 6, 21602, 10.1038/srep21602 Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method, Methods., 25, 402, 10.1006/meth.2001.1262 Lopez-Dee, 2011, Thrombospondin-1: multiple paths to inflammation, Mediat. Inflamm., 2011, 296069, 10.1155/2011/296069 Lv, 2019, Corilagin alleviates acetaminophen-induced hepatotoxicity via enhancing the AMPK/GSK3beta-Nrf2 signaling pathway, Cell Commun. Signal., 17, 2, 10.1186/s12964-018-0314-2 Matkowskyj, 1999, Azoxymethane-induced fulminant hepatic failure in C57BL/6J mice: characterization of a new animal model, Am. J. Phys., 277, G455 McMillin, 2019, The TGFbeta1 receptor antagonist GW788388 reduces JNK activation and protects against acetaminophen hepatotoxicity in mice, Toxicol. Sci., 170, 549, 10.1093/toxsci/kfz122 Mirochnik, 2008, Thrombospondin and apoptosis: molecular mechanisms and use for design of complementation treatments, Curr. Drug Targets, 9, 851, 10.2174/138945008785909347 Mosher, 1982, Synthesis and secretion of thrombospondin by cultured human endothelial cells, J. Cell Biol., 93, 343, 10.1083/jcb.93.2.343 Munger, 1997, Latent transforming growth factor-beta: structural features and mechanisms of activation, Kidney Int., 51, 1376, 10.1038/ki.1997.188 Munger, 1999, The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis, Cell., 96, 319, 10.1016/S0092-8674(00)80545-0 Neuschwander-Tetri, 2006, Induced thrombospondin expression in the mouse pancreas during pancreatic injury, Int. J. Biochem. Cell Biol., 38, 102, 10.1016/j.biocel.2005.08.008 Qu, 2018, Thrombospondin-1 protects against pathogen-induced lung injury by limiting extracellular matrix proteolysis, JCI Insight, 3, 10.1172/jci.insight.96914 Raucy, 1989, Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2, Arch. Biochem. Biophys., 271, 270, 10.1016/0003-9861(89)90278-6 Resovi, 2014, Current understanding of the thrombospondin-1 interactome, Matrix Biol., 37, 83, 10.1016/j.matbio.2014.01.012 Ribeiro, 1999, The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta, J. Biol. Chem., 274, 13586, 10.1074/jbc.274.19.13586 Schultz-Cherry, 1993, Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism, J. Cell Biol., 122, 923, 10.1083/jcb.122.4.923 Seif, 2018, Neutrophil-Mediated Proteolysis of thrombospondin-1 promotes platelet adhesion and string formation, Thromb. Haemost., 118, 2074, 10.1055/s-0038-1675229 Shi, 2004, GADD34-PP1c recruited by Smad7 dephosphorylates TGFbeta type I receptor, J. Cell Biol., 164, 291, 10.1083/jcb.200307151 Starlinger, 2011, Platelet-stored angiogenesis factors: clinical monitoring is prone to artifacts, Dis. Markers, 31, 55, 10.1155/2011/535109 Suzuki, 2015, Upregulation of thrombospondin 1 expression in synovial tissues and plasma of rheumatoid arthritis: role of transforming growth factor-beta1 toward fibroblast-like synovial cells, J. Rheumatol., 42, 943, 10.3899/jrheum.141292 Wang, 2018, Fucoidan alleviates acetaminophen-induced hepatotoxicity via oxidative stress inhibition and Nrf2 translocation, Int. J. Mol. Sci., 19, 10.3390/ijms19124050 Warren, 2018, Activation of latent transforming growth factor-beta1, a conserved function for pregnancy-specific beta 1-glycoproteins, Mol. Hum. Reprod., 24, 602, 10.1093/molehr/gay044 Yu, 2000, Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis, Genes Dev., 14, 163, 10.1101/gad.14.2.163 Zhang, 1996, Receptor-associated mad homologues synergize as effectors of the TGF-beta response, Nature., 383, 168, 10.1038/383168a0